Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024 J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;

Prevalence of methanogens and associated factors in patients with irritable bowel syndrome and healthy controls in a Southeastern Mexican population M.G. Aja-Cadena; M. Amieva-Balmori; H.A. Taboada-Liceaga; O.J. Cobos-Quevedo; G.A. Hernández-Ramírez; J. Reyes-Huerta; F. Roesch-Dietlen; A. Meixuerio-Daza; J.M. Remes-Troche;

Survey of Latin American gastroenterologists, specialists in disorders of gut-brain interaction, on the diagnosis and treatment of irritable bowel syndrome in clinical practice I. Hanna-Jairala; G.A. Puentes-Leal; A.M. Madrid; L. Aguilar-Paiz; J. Suazo-Barahona; J.M. Remes-Troche; E. Coss-Adame; L.M. Bustos-Fernández; L. Solé; M. Gudiño-Zayas; M. Schmulson;